Sentence examples for misclassification is less from inspiring English sources

As discussed above, in the previous case control analyses, the impact of misclassification is less predictable.

In addition, because diet is not an established BC risk factor, differential misclassification is less likely.

The argument which is often brought forward that such misclassification is less serious because it leads to a more conservative estimate, is questionable as also underestimations are non-valid and therefore unwanted.

The misclassification was less than 2%.

When the ratio of the number of observed naïve tests to the number observed experienced tests was high (i.e. in 1997, 2005-2007), theffectct of adjusting for misclassification was less than for years when the ratio was low.

In particular for exposures during the first year of life, when inhalant allergen sensitization was considered separately, participants for whom exposure misclassification was less likely (i.e., those spending more than the city median time at home, and those who did not attend daycare) had stronger associations.

The misclassification percentage is less than 13%.

Of course, a chance finding could be an explanation given multiple testing but it should also considered that women are a more stable population than men and misclassification of exposure is less likely to have occurred.

Although finer resolution data may have helped alleviate these exposure misclassification issues it is less likely that any such data, if available, would be readily available for the whole UK and/or routinely updated.

In order to compare the classifier performance to the inter-annotator agreement, we have selected four measures that incorporate to a different degree the idea that the misclassification of Neutral stance is less important than the misclassification of the extremes, i.e., Leave vs Remain: Alpha, (overline{F_{1}}), ({Accuracy}), and ({Accuracy},!pm,!1)  (see details in "Methods").

This misclassification is much less likely to occur in Europe or North America, where the prevalence of CS in sarcoidosis patients is markedly lower.